Results 81 to 90 of about 4,950 (174)

Correlation of copeptin with osmolarity and electrolytes in diabetes Mellitus: A tertiary center outpatient experience.

open access: yesInternational Journal of Endorsing Health Science Research, 2022
Background: Arginine Vasopressin (AVP) plays a significant role in the pathophysiology of Diabetes Mellitus (DM) and its related nephropathy. Timely detection of copeptin, a surrogate biomarker of AVP, would help in minimizing the osmoregulatory ...
Tooba Noor   +4 more
doaj  

Estimation the activity of Copeptin, insulin, and C-peptide from patients with polycystic ovary syndrome

open access: yesTikrit Journal of Pure Science, 2018
Copeptin, the C-terminal part of the vasopressin prohormone, is secreted stoichiometrically with vasopressin that is more easily measured than Arginine vasopressin.
Entedhar R. Sarhat, Madlen Qassm Abbas
doaj   +1 more source

Copeptin in heart failure

open access: yes, 2014
Bartosz Lasota,1 Katarzyna Mizia-Stec212nd Department of Cardiology, Medical University of Silesia, Katowice, Poland; 21st Department of Cardiology, Medical University of Silesia, Katowice, PolandAbstract: Copeptin is a novel indicator of arginine&ndash ...
Lasota B, Mizia-Stec K
core  

Copeptin as an inflammatory marker in diagnosis and prognosis of neonatal sepsis

open access: yesBeni-Suef University Journal of Basic and Applied Sciences
Background Copeptin is an immediate biomarker of individual stress response; many life-threatening diseases are causing a high elevation of its concentration in plasma, such as myocardial infarction and cardiovascular shock.
Amna G. Mabrouk   +4 more
doaj   +1 more source

Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset.

open access: yes, 2016
BACKGROUND Patients presenting very early after chest pain onset may provide a diagnostic challenge even when using a high-sensitivity cardiac troponin (hs-cTnT).
Rubini Gimenez, Maria   +12 more
core   +1 more source

Copeptin and metabolic syndrome: a systematic review [PDF]

open access: yes, 2022
Background: Copeptin, a reliable marker for vasopressin release, has been associated with cardiometabolic diseases including metabolic syndrome (MetS). This systematic review aims to evaluate the association between copeptin and MetS.
Galindo Yllu, Brenda Mireya
core  

Copeptin for Early Diagnosis of Myocardial Infarction

open access: yes, 2015
Background: Early identification of myocardial infarction is crucial in chest pain patients. Objective: Our goal was to evaluate if copeptin allows the ruling out of myocardial infarction (AMI) when used with cardiac troponin Ic (troponin) in the ...
Victorine Walter   +7 more
core   +1 more source

Copeptin is associated with mortality in elderly people

open access: yes, 2021
Background: Elevated copeptin, a marker for vasopressin release, has been associated with impaired prognosis in acute myocardial infarction (MI). The aim was to investigate whether this association extends beyond the acute phase and whether it is related
Maria Isabel Smaradottir   +17 more
core   +1 more source

Copeptin; Utility in paediatric patients with hyponatraemia

open access: yes, 2021
\ua9 2021 S. Karger AG, Basel. All rights reserved. Introduction Copeptin concentrations are a useful component of the diagnostic work-up of paediatric patients with polyuria and polydipsia but the value of measuring copeptin in patients with ...
Cheetham TD   +5 more
core  

Comparison of ex vivo stability of copeptin and vasopressin [PDF]

open access: yes, 2017
BACKGROUND: Copeptin, part of the vasopressin precursor, is increasingly used as marker for vasopressin and is claimed to have better ex vivo stability. However, no study has directly compared the ex vivo stability of copeptin and vasopressin.
Boesten, Lianne S M   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy